Diurnal launches Efmody in Germany and Austria
LONDON: Diurnal Group plc announced the launch of Efmody (hydrocortisone modified-release hard capsules) in Germany and Austria as treatment of adult and adolescent patients (12 years and older) with the rare condition congenital adrenal hyperplasia (CAH), following approval by the…